Clinical Trial Update: Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome [Phase 3]

View source ↗

Summary

Phase III double-blind, placebo-controlled trial of tamsulosin in male patients with Lower Urinary Tract Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Tract Diseases | Phase 3 | Status: COMPLETED